Companies: 10,795·Total market cap: $144.5T
Gamida Cell Ltd.

Gamida Cell Ltd.

GMDANASDAQHealthcare
$0.03
+$0.00(+0.00%)
Market Cap$4337295
P/E Ratio
52W High$0.0395
52W Low$0.0327

Gamida Cell Ltd. (GMDA) Market Cap & Net Worth

Live market cap, enterprise value, and global rank — multi-year chart and annual table below.

gmda · market cap & enterprise value · FMP · as of Jun 17, 2025

Core market cap & key metrics

As of Jun 17, 2025, Gamida Cell Ltd. (GMDA) has a market cap — also referred to as its net worth or valuation — of $4,337,295, making it one of the top most valuable companies globally. Market Cap = $0.03 × shares outstanding.

Market Cap (Net Worth)$4,337,295gmda market cap 2026
Enterprise ValuemktCap + debt − cash
1-Year Changevs one year ago
Global Rankinglargest company by mkt cap
All-Time High$0gmda highest market cap ever
Stock Price$0.03NASDAQ · Jun 17, 2025
How is Market Cap calculated?Market Cap = Stock Price × Shares Outstanding

About Market Cap, Net Worth & Valuation

Gamida Cell Ltd. (GMDA) has a market cap — also referred to as its net worth or valuation — of $4,337,295 as of Jun 17, 2025, making it the #0 most valuable company globally. Market Cap = Stock Price × Shares Outstanding.

Gamida Cell Ltd. reached its all-time high market cap of $0 on —. Comparing the Gamida Cell Ltd. market cap history illustrates one of the most extraordinary corporate growth stories.

Investors frequently compare Gamida Cell Ltd. net worth vs peers and ask how Gamida Cell Ltd. valuation compares to other countries. Its market cap reflects continued investor confidence.

Data: FMP · year-end market cap · not investment advice

Frequently Asked Questions

GMDA market cap · 6 questions

Gamida Cell Ltd.'s net worth — measured as market capitalization — is $4,337,295 as of Jun 17, 2025. It ranks #0 globally. Market Cap = $$0.03 (price) × shares outstanding.

GMDA net worth 2026market cap vs book valuelargest companies by market cap
Data: Financial Modeling Prep · Market cap updates daily · For informational purposes only, not investment advice.